FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $0.89, $0.19 better than the analyst estimate of $0.70. Revenue for the quarter came in at $238 million versus the consensus estimate of $231.14 million.
GUIDANCE:
USANA Health Sciences sees FY2023 EPS of $2.65-$3.30, versus the... More

